ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

XERS Xeris Biopharma Holdings Inc

0.00
0.00 (0.00%)

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)
Total Revenue 25.31M29.73M33.14M33.2M38.01M48.32M44.39M40.64M
Operating Income -18.92M-18.78M-15.17M-13.28M-15.98M-4.91M-9.84M-14.25M
Pre Tax Income -26.52M-22.17M-13.27M-16.83M-20.52M-12.53M-13.63M-18.67M
Net Income -26.19M-21.83M-12.93M-16.83M-19.84M-12.19M-13.39M-18.98M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -23.79M-18.66M-10.76M-11.92M-15.2M-3.98M-7.71M-13.57M
EBITDA -15.85M-15.71M-12.09M-10.2M-12.88M-1.81M-6.78M-11.21M
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Revenue 49.59M110.25M163.91M
Operating Income -115.16M-81.94M-44.01M
Pre Tax Income -122.73M-96.08M-63.5M
Net Income -122.73M-94.66M-62.26M
Preferred Dividends 000
Basic Earnings Per Share (EPS) -0.983-0.695-0.451
EBIT -115.16M-85.1M-38.81M
EBITDA -113.28M-69.7M-31.68M